BLFS (BioLife Solutions) Interest Expense: $0.00 Mil (TTM As of Mar. 2026)

What is BioLife Solutions Interest Expense?

BioLife Solutions BLFS +4.25% 72 Interest Expense is $0.00 Mil as of Mar. 2026. GuruFocus rates BLFS with a GF Score™ of 72/100 and a GF Value™ of $28.57 (Fairly Valued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioLife Solutions's interest expense for the three months ended in Mar. 2026 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioLife Solutions's Operating Income for the three months ended in Mar. 2026 was $ 0.03 Mil. BioLife Solutions's Interest Expense for the three months ended in Mar. 2026 was $ 0.00 Mil. GuruFocus does not calculate BioLife Solutions's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioLife Solutions (NAS:BLFS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioLife Solutions's Interest Expense for the three months ended in Mar. 2026 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2026 was $0.03 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $10.04 Mil.

BioLife Solutions's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

GuruFocus does not calculate BioLife Solutions's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. BioLife Solutions Inc has enough cash to cover all of its debt. Its financial situation is stable.

BioLife Solutions Interest Expense Historical Data

* Premium members only.

The historical data trend for BioLife Solutions's Interest Expense can be seen below:

BioLife Solutions Interest Expense Chart

BioLife Solutions Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.49

-0.28

-1.41

-0.77

0.00

BioLife Solutions Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

72GF Score

BioLife Solutions Inc BLFS

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioLife Solutions Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $0.00 Mil mean?

BioLife Solutions (BLFS) has a Interest Expense of $0.00 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on BioLife Solutions and its competitors.

Is BioLife Solutions' Interest Expense too high?

BioLife Solutions' current Interest Expense is $0.00 Mil. Overall, BioLife Solutions has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does BioLife Solutions' Interest Expense compare to KMTS and AZTA?

BioLife Solutions' Interest Expense of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on BioLife Solutions and its competitors. BioLife Solutions's current Interest Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioLife Solutions stock overvalued right now?

Based on GuruFocus' analysis, BioLife Solutions (BLFS) is currently considered Fairly Valued. The stock's GF Value™ is $28.57, compared to a current price of $28.64 — trading 0.2% above its estimated fair value. The current Interest Expense is $0.00 Mil. BioLife Solutions' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For BioLife Solutions (BLFS), the current Interest Expense is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioLife Solutions (BLFS) Overvalued in 2026?

Based on GuruFocus' analysis, BioLife Solutions stock appears to be overvalued. The current stock price of $28.64 is trading 0.2% above its estimated GF Value™ of $28.57. GuruFocus considers BioLife Solutions to be Fairly Valued.

Key valuation signals for BLFS:

Interest Expense: $0.00 Mil
GF Value™: $28.57 vs. price of $28.64 (0.2% above fair value)
GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the BLFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioLife Solutions Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies KMTS AZTA ATRC STAA NNNN PLSE ANGO XRAY OSUR LMAT ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges BJX1:Germany

Address 3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website https://www.biolifesolutions.com

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

72GF Score

Get the complete analysis for BLFS

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.64

Price

$28.57

GF Value

View BLFS Analysis

See Interest Expense data for all stocks →